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Abstract
Background
Depression is commonly comorbid with many other somatic diseases and symptoms. Identi-
fication of individuals in clusters with comorbid symptoms may reveal new pathophysiologi-
cal mechanisms and treatment targets. The aim of this research was to combine machine-
learning (ML) algorithms with traditional regression techniques by utilising self-reported
medical symptoms to identify and describe clusters of individuals with increased rates of
depression from a large cross-sectional community based population epidemiological
study.
Methods
A multi-staged methodology utilising ML and traditional statistical techniques was performed
using the community based population National Health and Nutrition Examination Study
(2009–2010) (N = 3,922). A Self-organised Mapping (SOM) ML algorithm, combined with
hierarchical clustering, was performed to create participant clusters based on 68 medical
symptoms. Binary logistic regression, controlling for sociodemographic confounders, was
used to then identify the key clusters of participants with higher levels of depression (PHQ-
910, n = 377). Finally, a Multiple Additive Regression Tree boosted ML algorithm was run
to identify the important medical symptoms for each key cluster within 17 broad categories:
heart, liver, thyroid, respiratory, diabetes, arthritis, fractures and osteoporosis, skeletal pain,
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blood pressure, blood transfusion, cholesterol, vision, hearing, psoriasis, weight, bowels
and urinary.
Results
Five clusters of participants, based on medical symptoms, were identified to have signifi-
cantly increased rates of depression compared to the cluster with the lowest rate: odds
ratios ranged from 2.24 (95% CI 1.56, 3.24) to 6.33 (95% CI 1.67, 24.02). The ML boosted
regression algorithm identified three key medical condition categories as being significantly
more common in these clusters: bowel, pain and urinary symptoms. Bowel-related symp-
toms was found to dominate the relative importance of symptoms within the five key
clusters.
Conclusion
This methodology shows promise for the identification of conditions in general populations
and supports the current focus on the potential importance of bowel symptoms and the gut
in mental health research.
Introduction
Depression is a debilitating illness that is estimated to affect 350 million people globally and is
frequently associated with somatic symptoms and other medical conditions [1,2]. The nature
and direction of these relationships are often complex, interrelated, and difficult to unravel.
Depression classically presents with many and diverse somatic symptoms. The comorbidity of
depression with a number of chronic medical conditions, such as Irritable Bowel Syndrome
(IBS) [3], ischemic heart disease [4], cancer [5], diabetes [6], osteoporosis [7], thyroid disease
[8], and obesity [9], has also been well established. However, these conditions often have bidi-
rectional relationships with depression such that this level of comorbidity and interrelatedness
can complicate treatment and stymie efforts to identify causal factors in depression. Thus, the
identification of individuals in clusters of comorbid symptoms in depression may reveal new
pathophysiological mechanisms and treatment targets.
Due to the complexity and heterogeneity of medical data, previous studies have primarily
investigated individual medical conditions linked to depression. The use of “big data” and
machine-learning (ML) techniques and algorithms has the ability to handle heterogeneous
data without strict constraints and have been demonstrated to unearth key patterns and inter-
actions in health data [10,11]. The mapping of multidimensional data onto two-dimensional
maps [12–14] with ML techniques allows the researcher to visualise and interpret the complex-
ity of the data and generate new hypotheses regarding depression.
ML is a vast and expanding field of artificial learning where algorithms improve perfor-
mance through experiential learning [15]. In the health arena, ML algorithms that learn by
training on subsets of data have been used to fit models using supervised ML (i.e. where the
objective of the exercise is to establish the main inputs to predict known values) [16], and to
find patterns in data using unsupervised ML (i.e. where the objective is to uncover previously
unknown patterns and clusters within the data set, without any a priori model defined) [17].
Blending of unsupervised and supervised ML techniques has been used to detect patterns and
relationships within large numbers of complex lifestyle-environ variables [18]. Notoriously
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complex in nature, medical symptom data are ideally suited to blended ML techniques. Utilis-
ing the learning properties of ML it is possible to detect, visualize and understand the composi-
tion of medical symptoms clusters for those with psychiatric disorders such as depression.
[19,20]
ML techniques have been used across a variety of disciplines to explore and model very
large quantities of data to discover patterns, unsuspected relationships and useful rules for a
specific purpose. Often novel unsuspected and novel interpretations of the data (serendipity)
are uncovered. Commercially, these techniques have been used successfully for businesses to
learn from their transaction data about the behaviour of their customers, improving their busi-
ness model by exploiting this knowledge [21]. However, it has only been over the last 10 years
that ML techniques have been used in medical research, primarily in neuroscience and bio-
medicine [22,23]. More recently ML techniques have been used in psychiatry [10], using pre-
dominantly very big data sets. Complex survey methodologies are often implemented with
population-based data (e.g. oversampling in underrepresented groups, stratification, cluster-
ing) and traditional statistical techniques are capable of dealing with this complexity [24].
However, big data techniques on their own do not adequately account for this type of sample.
Thus, a blend of both big data ML techniques with traditional statistical techniques has the
potential to uncover hidden patterns while accounting for the complex sampling.
The aim of this research was to use data from a large cross-sectional community based pop-
ulation epidemiological study to combine unsupervised and supervised ML algorithms with
traditional regression techniques by utilising self-reported medical symptoms to identify and
describe clusters of individuals with increased rates of depression from a large cross-sectional
community based population epidemiological study.
Methods
Study design and participants
The 2009–2010 National Health and Nutrition Examination Survey (NHANES) (2009–2010)
[25] cross-sectional civilian noninstitutionalized population based data were utilised for this
study. This study included 18 to 80 year old non-institutionalised US civilians (N10,000)
and applied a complex four-stage sampling methodology: counties; segments within counties;
households within segments; and, individuals within households. Data were collected from 15
locations across 50 US states, with oversampling of subgroups of the population of particular
public health interest, to increase the reliability and precision of population estimates [25]. Ques-
tionnaire data relating to medical symptoms and demographics were downloaded from the
NHANES website and integrated using the Data Integration Protocol In Ten Steps (DIPIT) [26].
Variables were initially selected based on the criterion of relevance to medical symptoms.
Analysis was performed to minimise the degree of missing data across the set of medical symp-
toms. The final set of 68 dichotomous medical symptom variables and an unweighted sample
size of 3,922 was used for clustering in this research study. There were 377 participants identi-
fied with depression, being representative of the total depressed sample for NHANES during
2009–2010 (i.e. 8% after adjustment for the complex survey sample structure). The imbalanced
nature of the data was addressed in this study by identifying clusters with high rates of depres-
sion (i.e. high risk clusters) rather than individual participants with depression. This meant
that within each high risk cluster the imbalance was much reduced. This was the primary ratio-
nale for undertaking the Self-organised Mapping (SOM) and clustering of individuals, thereby
allowing the identification of the key clusters significantly associated with depression using
binary logistic regression. Finally, the most important medical symptoms for identifying
depressed individuals were identified for each of these key clusters.
Unravelling Medical Symptoms Associated with Depression
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NHANES received approval from the National Center for Health Statistics (NCHS)
research ethics review board and informed consent was obtained from all participants. Use of
data from the NHANES 2009–2010 database is approved by the National Center for Health
Statistics Research Ethics Review Board (Continuation of Protocol #2005–06).
Study Measurements
A self-reported Patient Health Questonnaire-9 (PHQ-9) [27] was used to assess depressive
symptoms (‘depression’). This questionnaire consisted of nine items that were summed to
form a total score. Those with a total score of 10 or more were considered moderately or
severely depressed [28]. The 68 medical symptom data were classified into 17 broad medical
categories: heart, liver, thyroid, respiratory, diabetes, arthritis, fractures and osteoporosis, pain
(i.e. neck, back, hip pain), blood pressure, cholesterol, vision, hearing, psoriasis, weight, bow-
els, urine, and if a blood transfusion was received. The self-report demographic and socio-eco-
nomic variables from the NHANES demographic and questionnaire data components were
also utilised [29].
Statistical Methodology
This research implemented two ML algorithms: an unsupervised algorithm, combined with
hierarchical clustering, to create the medical symptom clusters and a supervised algorithm to
identify and describe the key clusters with a significant relationship with depression. Due to
the complex sampling methodology of the NHANES data, traditional binary logistic regression
was implemented to identify these key clusters while controlling for potential socio-demo-
graphic confounders.
A summary of the statistical methodology, testing regime and results is outlined in Fig 1.
Medical symptom cluster identification
Self-organizing maps (SOMs) were introduced by Kohonen in 1995 [30] as a variant of artifi-
cial neural networking, inspired by biological neural networks, and have since been used in
many diverse applications across a variety of fields including bioinformatics, engineering,
financial analysis, experimental physics, and psychiatry [31,32]. SOMs provide a simple and
effective unsupervised ML algorithm for clustering individual participants and visualising high
dimensional data in a low dimensional map without any reliance on distributional
assumptions.
The SOM identifies clusters by effectively packing the dataset onto a q-dimensional plane
where data points “similar” to each other in the original multidimensional data space are then
mapped onto nearby areas of the q-dimensional output space. SOMs combine competitive
learning with dimensionality reduction by smoothing the clusters with respect to an apriori
grid. The SOM is called a topology-preserving map because multi-dimensional input data is
represented often by a two dimensional “map” of nodes where topological properties of the
input space are maintained.
The steps involved in the SOM competitive ML algorithm involve initially assigning ran-
dom vector weights to each node (or position on the grid), then randomly choosing data
points (participants) from the training data and presenting them to the SOM. The “Best
Matching Unit” (BMU) in the map is the node with a vector weight most similar to a data
point and nodes within the “neighbourhood” of each BMU are found. With each iteration, the
size of this neighbourhood decreases. The vector weights of nodes in the BMU neighbourhood
are adjusted closer to their associated data points. The size of these adjustments decrease with
each iteration and the magnitude of these adjustments is proportional to the proximity of the
Unravelling Medical Symptoms Associated with Depression
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Fig 1. Flowchart of Methods, Testing and Results.
doi:10.1371/journal.pone.0167055.g001
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node to the BMU. These steps are repeated for N iterations or until the vector weights for all
the nodes converge to their final values.
For this study a hexagonal map topology was used, with five SOM grids tested (10x10,
15x15, 20x20, 25x25, 30x30) to establish a map with suitable nodes. The final solution utilised
a 15x15 grid with a learning rate for weight adjustment declining linearly from 5% to 1% over
100 iterations. The unconstrained nature of the SOM technique meant that clusters of nodes
form naturally from the medical symptom data on the grid without the influence of the partici-
pant’s depressive symptom status. Hierarchical clustering, using the complete linkage method
[33], was then utilised to group SOM nodes with similar final weights, identifying the final
clusters. Three to 12 cluster solutions were considered and the cluster solution with the most
differentiation in terms of depression was chosen for further investigation. The clusters were
numbered in order of their rates of depression (i.e. frequency and average total PHQ-9 score).
Identification of key clusters with higher depression rates
Quantitative and qualitative investigation, using exploratory statistics of the resultant clusters
was used to establish variation with respect to depression rates and demographics.
Demographic factors were included in a binary logistic regression model to identify the key
participant clusters with a significant positive relationship with depression, accounting for the
complex survey design of NHANES. This model controlled for potential confounders and
quantified the probability of depression within each cluster. The cluster with the lowest depres-
sion rate was chosen as the reference group. This stage of the analysis was used to identify par-
ticipant clusters with significant rates of depression in order to identify the important medical
symptoms from the ML boosted regression. Only these key clusters were used in the next stage
of supervised ML boosted regression. No further investigation was performed on those clusters
with non-significant odds ratios for depression.
Medical symptoms most prominent within key clusters
Supervised ML boosted regression [34], translated to a binary logistic regression analysis [35],
was implemented for each of the key clusters to identify the most prominent medical symp-
toms associated with depression within these clusters. This technique has been previously used
to identify biomarkers associated with depression [36] and to describe lifestyle clusters associ-
ated with depression [18] using data from the NHANES study. Depression was considered as a
binary outcome and run for each key cluster using Friedman’s Multiple Additive Regression
Trees (MART) boosted algorithm [37,38]. Consistent with previous research using this ML
algorithm on the 2009 to 2010 NHANES data [36], validation was performed using a random
split of each data set into 60% training and 40% validation, a regularization shrinkage parame-
ter of 0.001, with 50% of the residuals used to fit each successive tree (50% bagging) [37]. The
maximum number of boosting interactions (i.e. number of terminal nodes plus 1) allowed was
six, being marginally higher than the default (i.e. five) and within the recommended range
[35]. Whilst this technique has been used for predictive purposes [16], it also has the ability to
be used as a variable selection method [36]. This method was used as a variable selection tech-
nique to identify the prominent medical symptoms associated with depression within the key
clusters [37]. A relative importance (or contribution) of each medical symptom variable for
each of the key significant clusters was produced from the ML boosted regression. Higher val-
ues of relative importance for a medical symptom within a particular key cluster indicates a
stronger relationships with depression in this cluster. This technique for variable reduction has
been recognised as effective [39] and previously used to delineate lifestyle clusters associated
with depression [18].
Unravelling Medical Symptoms Associated with Depression
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Those medical symptoms explaining at least 80% of the total log likelihood variation across
clusters were used to identify the most important medical symptoms for explaining differences
across clusters. Resultant medical symptoms were then grouped into the 17 broad medical
categories.
The SOMs and hierarchical clustering were performed in R with the SOM using the Koho-
nen package [13]. The boosted regression and binary logistic regression statistical procedures
were performed using Stata V14 software (StataCorp., 2014), with a Stata plugin for the
boosted regression component of the analysis [38].
Results
A summary of the results from the testing is presented in Fig 1.
SOM Clusters
The distance from each node’s weights to the sample of people represented by that node was
reduced to a minimum plateau as the SOM training iterations progressed, indicating that no
more iterations were required (Fig 2). Taking into account the heterogeneous nature of the
Fig 2. Training progress and SOM plots. Note: The “Training progress” graph indicates as the SOM training iterations distance from each
node’s weights to the samples represented by that node reduces and plateaus to indicate no more iterations were required. The “Counts plots”
indicates reasonable samples were mapped to each node on the map. The “Neighbour distance plot” or U-Matrix indicates the distance between
each node and its neighbours.
doi:10.1371/journal.pone.0167055.g002
Fig 3. Hierarchical Cluster Options for SOM. Note: Clusters 3 to 12 solutions mapped onto the SOM grid. Colours indicate
different clusters. The final 10 cluster solution selected for further analysis has been highlighted with a red border.
doi:10.1371/journal.pone.0167055.g003
Unravelling Medical Symptoms Associated with Depression
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self-reported medical symptom data, the counts plot indicated a reasonable distribution of
people numbers across the map. The neighbour distance plot indicated the distances between
each node and its neighbours were mostly similar with only a few dissimilar nodes, later identi-
fied as outlying clusters (Fig 2).
Three to 12 cluster solutions were considered (Fig 3) and the 10 cluster solution was
selected for further investigation because of clear cluster differences in terms of depression
rates. There were some isolated nodes in this cluster solution, later confirmed as outliers.
The final 10 cluster solution contained two dominant clusters (Table 1). One cluster was
dropped from further analysis due to very low frequency (n = 8), leaving 9 of the 10 clusters
for further analysis.
Cluster validation
Initial investigation into the relationship between the remaining nine participant clusters and the
depression measures revealed that the clusters exhibited an order with respect to both the percent-
age of participants depressed within each cluster and the average depression score (Fig 4).
An initial inspection of the socio-demographics for the nine clusters (Table 2) showed clear
differences. Due to the small frequencies for many of the clusters, only a qualitative investiga-
tion of socio-demographic differences was performed. Cluster 1 (n = 3,108) exhibited socio-
demographics closest to the total across all cluster participants. Cluster 2 (n = 34) consisted of
mostly male, non-Hispanic white with a high family income poverty ratio [40,41] and who
were less likely to have never married. Cluster 3 (n = 57) consisted mostly of male, non-His-
panic white, older, married / with a partner, a household size of around two people, and a low
family income poverty ratio. Cluster 4 (n = 446) members were more likely to be female, non-
Hispanic white, middle aged, with a low family income poverty ratio, and less likely to have
never been married. Cluster 5 (n = 50) were more likely to be older, non-Hispanic black, with
a low family income poverty ratio, and less likely to never have been married. Cluster 6
(n = 83) members were more likely to be male, older, less than three members in the house-
hold, non-Hispanic white, and of low to mid family income poverty ratio, and less likely to
have never been married. Cluster 7 (n = 55) were more likely to be middle aged, Mexican /
Hispanic, with a low family income poverty ratio and less likely to have never been married.
Cluster 8 (n = 52) were more likely to be female, older, non-Hispanic white, around two mem-
bers in the household, with low family income poverty ratio and less likely to have been
Table 1. Frequency Distribution of Initial Depression Ordered SOM Cluster Solution.
Cluster Frequency Percent
1 3,108 79.25
2 34 0.87
3 57 1.45
4 446 11.37
5 50 1.27
6 83 2.12
7 55 1.4
8 52 1.33
9 29 0.74
10 (Dropped) 8 0.2
Total 3,922 100
Note: Dominant clusters in bold. Cluster shaded dropped due to very small base (n = 8).
doi:10.1371/journal.pone.0167055.t001
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married. Cluster 9 (n = 29) were more likely to be young Mexican / Hispanic, with a large
household and low family income poverty ratio.
Identification of key clusters with higher depression rates
The final binary logistic regression with depression as the outcome took into account the com-
plex survey data of NHANES, as well as non-linearity, interactions and potential confounders
(Table 3). The test for goodness of fit were not significant for the model indicating a good fit to
the data (F(9,8) = 1.77, p = 0.216) [42]. Clusters 4 and 6 to 9 had significantly higher rates of
depression than cluster 1 after controlling for the potential socio-demographic confounders.
These five clusters were considered the key clusters for further analysis. Since the odds ratios
for depression for clusters 2, 3 did not significantly differ from cluster 1 these clusters were
excluded from future analysis. A significant interaction was found between the cluster with the
highest rate of depression (cluster 9) and the family income poverty ratio (p = 0.036) (Fig 5).
Thus, the relationship between the probability of depression and cluster 9 varied depending
upon the rate of the family poverty income ratio.
Fig 4. Mean depression scores and percent depression across final depression clusters. Note: “Mean Depression Score” is the average total PHQ-
9 score which ranged from 0 to 27. “Percent Depressed” based on a total PHQ-9 10.
doi:10.1371/journal.pone.0167055.g004
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Medical symptoms most prominent within key clusters
ML boosted regression was used to establish which medical symptoms were associated with
depression for each of the five key significant clusters. The top medical symptom variables
explaining approximately 80% of the total log likelihood for each cluster were selected for cate-
gorisation and further investigation. Bowel symptoms (e.g. bowel movements per week, stool
type) dominated the relative importance percentage across all the five key clusters (Fig 6). Fur-
ther investigation into the top 3 to 10 ranked medical categories from the ML boosted regres-
sion found that bowel, pain and urine symptoms consistently exhibiting a relatively high
importance percentage for each of the key clusters.
The top 10 key medical symptom categories for the five key significant clusters indicated
that each cluster exhibited different medical symptoms (Fig 7). However, bowel symptoms
were consistently included in the highest ranked medical symptoms across all five significant
depressive key clusters. In addition, the bowel symptoms dominated for cluster 7 and cluster 9,
and had relatively high importance (i.e. >5%) for four of the five key clusters. Pain symptoms
had the highest relative importance in cluster 4 and urine symptoms had relatively high impor-
tance (i.e. <10%) for two of the five key clusters. Whilst hearing symptoms were important in
all five of the key clusters, they only dominated in cluster 8.
Table 2. Demographic Profile Across SOM Clusters.
CLUSTER Total 1 2 3 4 5 6 7 8 9
Sample (n)* 3,914 3,108 34 57 446 50 83 55 52 29
Demographics
Gender:
Male 49.6% 50.8% 60.4% 60.2% 38.9% 43.1% 63.9% 41.2% 31.2% 57.4%
Female 50.4% 49.2% 39.6% 39.8% 61.1% 56.9% 36.1% 58.8% 68.8% 42.6%
Mean age (years) 42.44 42.08 48.17 53.05 46.09 51.60 56.24 44.30 55.93 38.67
Marital status:
Never 19.3% 20.4% 15.0% 11.6% 15.8% 14.6% 7.8% 14.7% 7.6% 19.6%
Married/Partner 65.3% 65.5% 66.4% 76.6% 64.7% 65.2% 63.9% 66.8% 48.9% 63.6%
Widowed/Divorced/Separated 15.4% 14.1% 18.6% 11.8% 19.6% 20.3% 28.4% 18.6% 43.5% 16.8%
Mean household size 3.22 3.23 3.19 2.23 3.07 2.95 2.64 3.26 2.55 3.94
Mean family size 3.02 3.03 3.07 2.94 2.91 2.75 2.49 2.94 2.39 3.88
Race:
Mexican/Hispanic 14.3% 14.4% 6.0% 17.3% 15.3% 13.3% 5.6% 27.0% 2.6% 45.5%
Non-Hispanic white 67.5% 67.6% 78.4% 66.3% 67.3% 54.0% 74.2% 55.4% 81.3% 26.0%
Non-Hispanic black 11.4% 10.9% 15.6% 5.9% 12.8% 27.0% 17.4% 14.6% 10.1% 16.5%
Other 6.7% 7.1% 0.0% 10.4% 4.6% 5.7% 2.8% 2.9% 6.1% 12.0%
Family income poverty ratio**:
Low 31.0% 29.2% 29.9% 39.8% 35.7% 42.6% 32.7% 64.9% 58.9% 68.8%
Middle 24.0% 24.5% 10.5% 19.0% 22.9% 23.4% 31.3% 15.9% 21.5% 11.2%
High 45.0% 46.4% 59.6% 41.2% 41.5% 33.9% 36.0% 19.2% 19.6% 20.0%
Mean family income poverty ratio:
(Note: 1 = poverty line) 3.03 3.16 3.39 2.80 2.89 2.68 2.91 1.82 2.09 1.68
Note: Figures quoted take account of the survey design of NHANES with 15 strata, 31Primary Sampling Units (PSU).
*Total sample size varies per demographic as base includes all those with a depression score and valid answer given for demographic.
**Family income poverty ratio represents the ratio of family or unrelated individual income to their appropriate poverty threshold where groupings are based
on eligibility for Special Supplemental Nutrition Program for Women, Infants, and Children (WIC): Low = 0.00–1.85 family income poverty ratio, Middle =
>1.85–3.50 family income poverty ratio, and High = >3.50 and above family income poverty ratio.
doi:10.1371/journal.pone.0167055.t002
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The individual clusters showed clear delineation with respect to medical conditions. The
top three medical symptoms for cluster 4 related to the skeletal symptoms of pain, fractures
and osetoporosis, and bowel symptoms. Cluster 6 was dominated by urinary medical symp-
toms. Cluster 7 was clearly dominated by bowel medical symptoms. Cluster 8 was a generally
Table 3. Binary Logistic Regression Model Odds Ratios with 95% Confidence Intervals.
Depression OR p-value 95% CI Low 95% CI High
Cluster 1 (reference) 1.00
Cluster 2 1.67 0.341 0.55 5.04
Cluster 3 1.98 0.151 0.76 5.20
Cluster 4 2.24 <0.001 1.56 3.24
Cluster 5 2.10 0.180 0.68 6.43
Cluster 6 3.78 <0.001 2.17 6.57
Cluster 7 4.61 <0.001 2.21 9.63
Cluster 8 7.80 0.001 2.86 21.33
Cluster 9 6.33 0.010 1.67 24.02
Cluster 9 X Family income poverty ratio 2.00 0.036 1.05 3.81
Gender
Male (reference) 1.00
Female 1.86 0.002 1.31 2.64
Age group
18–24 years (reference) 1.00
25–34 1.37 0.326 0.71 2.63
35–44 1.61 0.177 0.79 3.29
45–54 1.92 0.023 1.11 3.34
55+ 1.22 0.545 0.62 2.39
Marital status
Never married (reference) 1.00
Married/living with partner 0.54 0.007 0.35 0.82
Widowed/Divorced/Separated 0.79 0.172 0.55 1.12
Gender
Race
Non-Hispanic white (reference) 1.00
Mexican American / Hispanic 0.88 0.368 0.67 1.17
Non-Hispanic Black 1.17 0.436 0.77 1.76
Other 0.77 0.391 0.42 1.43
Education
Grades 11 and below (reference) 1.00
High School / GED Equivalent 0.43 0.039 0.20 0.95
Some College / AA / College or Above 0.59 0.008 0.40 0.85
Family income poverty ratio 0.60 0.002 0.45 0.80
Education X Family income poverty ratio
Grades 11 and below (reference) 1.00
High School / GED Equivalent 1.43 0.073 0.96 2.11
Some College / AA / College or Above 1.24 0.089 0.96 1.58
Constant 0.16 <0.001 0.08 0.34
Note: OR = Odds Ratio, CI = Confidence Interval. Multivariate logistic model taking account of complex
survey methodology (N = 3,584, 15 Strata, 32 PSUs). Bold p-values indicate significant p<005. Cluster 9
OR = 12.67 (95% CI: 1.75, 91.56) taking into account the interaction.
doi:10.1371/journal.pone.0167055.t003
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Fig 5. Predicted probability of depression across age and family income poverty ratio for each cluster.
doi:10.1371/journal.pone.0167055.g005
Fig 6. Importance of medical categories that make up the key significant clusters. Note: Based on total boosted relative importance
percentage across all clusters. Summed percentage from boosted regression across all five key significant clusters, thus total >100%.
doi:10.1371/journal.pone.0167055.g006
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unwell cluster with the top five medical symptoms related to hearing, pain, bowels, respiratory
and heart. Finally the top two medical symptoms for cluster 9 related to bowels and urine.
Discussion
Irrespective of country, research has consistently found a high level of comorbidity between
specific (e.g. sleep, appetite) and nonspecific symptoms and depression [43,44] but it has been
difficult to identify the key somatic symptoms most prominent in this condition. This study
utilized two machine learning techniques, complemented by traditional binary logistic regres-
sion analyses, to detect complex interactions between large numbers of medical symptoms in
order to identify those most strongly linked to depression in an atheoretical manner. ML tech-
niques have been used in the area of big data informatics in mental health. For example, text
analysis [45] and regression models [46] have been used to predict the risk of suicide from
clinical notes, but these techniques have not previously been used to investigate the relation-
ship between depression and medical symptoms using epidemiological community based pop-
ulation data. The visual simplification of complex medical symptom data into clusters, using
SOM, allows the researcher to easily identify the strength of the similarities across the map.
The ML SOM’s intention to mimic an artificial network that learns, without supervision, has
proven effective in creating nodes, subsequently grouped into clusters identified by a standard
hierarchical clustering. Nine clusters of participants based on medical symptoms were found
using the unsupervised graphical SOM ML technique. Traditional binary logistic regression
showed that five of the nine clusters were characterised by higher rates of depression after con-
trolling for potential confounders and taking account of the complex survey methodology of
the population data.
A boosted regression ML algorithm was used to provide a relative importance percentage
for each medical symptom for each of the five key significant clusters, allowing the easy group-
ing of symptoms into medical categories. The ML boosted regression algorithm was able to
Fig 7. Total percentage importance of medical conditions for each key significant cluster. Note: Clusters presented in order of percent
depressed. Note: Percentage sum does not take account of direction of relationship.
doi:10.1371/journal.pone.0167055.g007
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untangle the array of medical symptoms and detect three key medical condition categories as
being particularly related to depression: bowel, pain and urinary symptoms. Of these catego-
ries, bowel symptoms dominated, validating previous research regarding the high comorbidity
between gut symptoms and IBS with common mental disorders, including depression [3,47].
Gut disorders in particular share links with depression. Irritable bowel syndrome (IBS) [3]
has been found to be closely associated with mental health conditions. IBS is not only comor-
bid with psychiatric conditions, but also comorbid with non-gastrointestinal somatic disorders
[48]. Crohn’s disease [49] and gastro-oesophageal reflux disease (GORD) [50] are similarly
associated with higher rates of mood disorders than would be expected by chance. All these
interrelationships impact on the quality of life, treatment compliance, length of stay in hospi-
tals, costs of health care, morbidity and possibly mortality of individuals affected.
Medical symptoms relating to stool type and frequency and constipation were included in
the bowel categorisation for this study, and these indicators have all been related to mood [51].
Recently, ML boosted regression has identified an association between the gastrointestinal bio-
marker of bilirubin with depression [36] and bilirubin has been linked to varying stool type
based on the speed at which the intestinal contents travel through the bowel [52].
There is an increasing focus in medical research on the role of symbiotic gut microbiota in
health and disease, including mental health. Indeed, the human gut microbiota, and what is
termed the ‘gut-brain axis’, are now increasingly regarded as potentially critical drivers of
mood and behaviour, with much of the biological dysregulation associated with depressive
symptoms and the diagnosis of clinical depression influenced by the gut microbiota [53]. Such
microbiota-influenced dysregulation involves inflammatory, metabolic, oxidative stress, HPA
axis, neurotransmitter/neuropeptide, brain plasticity and other systems [54]. Moreover, the
normal intestinal barrier function is compromised in depression [55]. This ‘leaky gut’ allows
intestinal-microbe-derived lipopolysaccharide (LPS), an endotoxin, to gain access to the
periphery. Even very low levels of LPS can provoke much of the aforementioned biological
dysregulation noted in depression.
Importantly, many of the lifestyle and environmental factors connected to depression have
a detrimental influence on the composition of the normal human microbiota. As just one
example, unhealthy dietary patterns that increase the risk for depression [56] also diminish
microbial diversity [57]. Long-term, habitual diets are one of the strongest influences on gut
microbial composition, determining an individual “enterotype” [58], however dietary change
can prompt change in gut microbiota composition within 24 hours [59]. The consumption of
complex carbohydrates, plant-based foods/fruits and vegetables [58,60] positively influences
microbial composition, synthesis of anti-inflammatory short chain fatty acids, and host health.
Conversely, high fat diets trigger microbial dysbiosis, intestinal permeability (‘leaky gut’) and
inflammation [61]. We have previously demonstrated that healthy dietary patterns are associ-
ated with a reduced likelihood of depressive symptoms in adults participating in the NHANES
[62]. This suggests that unhealthy dietary behaviors may be a key factor negatively influencing
both gut health and depression, with bowel symptoms signifying poor gut health.
Strengths and Limitations
The strengths of this study lie in the benefits of using both unsupervised and supervised ML
techniques to identify patterns in data, using a large number of heterogeneous self-reported
medical symptoms to form five clusters of individuals with relatively high rates of depression,
most likely to have remained hidden using traditional statistical techniques. The largest cluster
of participants (cluster 4, n = 446) comprised 7% moderately and 7% severely depressed partic-
ipants; this compares to rates of 5% and 3% respectively in the general 2009 to 2010 US
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population in NHANES. The remaining key clusters (6 to 9) consisted of smaller groups of
participants, with 15% moderately and 14% severely depressed participants overall. A main
limitation with this study is the cross-sectional nature of the NHANES data that restricts the
ability to infer causality. However, the use of this community population based survey data has
the advantage of being representative of the large US population sampled during 2009 to 2010.
The large number of participants included in this study, with its rigorous complex survey sam-
pling methodology, ensures the data possess a good description of the relative characteristics
of the civilian noninstitutionalised US population. As compared to other methods of data gath-
ering, surveys are able to extract data that closely mirror attributes of the larger population.
It is acknowledged that the PHQ-9 instrument relates to depressive symptoms, and does
not represent a clinical diagnosis of depression. Thus, this self-report instrument may have
missed less severe cases of depression [27,28] exaggerating the imbalance in the data. Further-
more, the depression symptoms picked up by the PHQ-9 instrument for this study, such as
fatigue, psychomotor problems, or insomnia are symptoms very common in medical condi-
tions. Thus, it was not surprising that the results from this study confirmed prior research
identifying depressive symptoms being often elevated in people with medical symptoms [63].
The relationship between medical symptoms and depression is complex and often bidirec-
tional. However, the identification of the dominant medical symptoms, such as those of the
bowel cluster in this study, may be used to improve screening tools for depression in medically
ill patients and to shed light on possible pathogenic processes. It is acknowledged that individ-
uals with depression are more likely to report somatic conditions, and IBS has been found to
be a disorder with a psychosomatic aspect [47]. However, the NHANES study is considered
representative of the US noninstitutionalised civilian population and has been used to produce
health statistics for the US and in many studies investigating depression (e.g. to examine the
prevalence, treatment and control of depressive symptoms [64]).
We addressed the limitation of the imbalance in the data of having only approximately 8%
of the sample classified with depression by including only those clusters with high depression
rates, hence reducing the impact of this imbalance on our analysis.
There are potential limitations in using the proposed ML techniques. The SOM can become
conceptually expensive as the number of variables and the grid size increases, causing the
number of distances the algorithm needs to compute to increase exponentially. In addition,
the SOM requires a value for each variable for each participant in order to generate a map, so
missing data poses issues for map generation with SOMs. Alternative less computer intensive
traditional statistical techniques, such as k-means clustering or latent class analysis, could have
been used. However, the SOM algorithm has been found to provide better results than either
of these methods in the case of large data sets [65–67] such as used in this study.
The ML boosted regression has the advantage of automatically incorporating interaction
effects when evaluating variable importance which is not possible with traditional statistical
regression modelling [37]. Also, variable selection processes, such as stepwise or regularized
regression make variable selection difficult when there are highly correlated predictors as is
the case with medical symptoms. The boosted regression overcomes this problem by reducing
the number of selected variables at each iteration thereby being able to deal with highly corre-
lated variables. However, ML boosted regression can fail to perform well with small data sets
[68]. In addition, the training process can be computationally memory intensive due to the
fact that trees are built sequentially, requiring advanced computing capability such as parallel
processing. In addition, the regularization implemented to reduce the effects of overfitting can
mean the optimal number of iterations for a suitable shrinkage parameter can be considerably
large [69].
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Whilst this study performed validation using a random split of data into 60% training and
40% validation at the ML boosted regression stage, no validation of the methodology was per-
formed on a separate data set using self-reported medical symptom data. However, this meth-
odology has been successfully implemented to identify lifestyle clusters associated with
depression [70].
Conclusion
This study implemented two ML algorithms and a standard binary logistic regression to iden-
tify and describe clusters of individuals with higher rates of depression based on self-reported
medical symptoms in a large, cross-sectional epidemiological community based population
study. Bowel symptoms, covering bowel frequency and stool type, were identified as the pre-
dominant concurrent symptom category for the key clusters with a significant positive rela-
tionship with depression across 17 varied medical symptom categories. This study encourages
the future use of machine learning techniques to compliment traditional statistical approaches
in the analysis of epidemiological studies to assist clinicians detect potential latent associations
that can be further refined and clarified. This study also supports a research focus on the
potential importance of the bowel symptoms, the gut and its resident microbiota in mental
health research.
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